A Phase 2/3, Open-Label Study of t and Childrenhe Pharmacokinetics, Safety, and Antiviral Activity of the GS-9883/Emtricitabine/Tenofovir Alafenamide (GS-9883/F/TAF) Fixed Dose Combination (FDC) in HIV-1
Clinical Trial Grant
Administered By
Pediatrics, Infectious Diseases
Awarded By
Gilead Sciences, Inc.
Start Date
January 31, 2017
End Date
May 31, 2023
Administered By
Pediatrics, Infectious Diseases
Awarded By
Gilead Sciences, Inc.
Start Date
January 31, 2017
End Date
May 31, 2023